Obsessive-compulsive disorder affects approximately 2 to 3 percent of the global population, over 2 million Americans, and roughly 40 to 60 percent of those individuals do not experience adequate relief from first-line treatments including SSRIs, clomipramine, and exposure and response prevention therapy. At Edelica Health, we work with patients who have lived with severe, treatment-resistant OCD and who have reached out to us after exhausting conventional options. Ketamine represents one of the most biologically interesting emerging options in this space, and we want to give patients an honest account of what the evidence shows.
Why Ketamine May Work Differently for OCD
OCD is characterized by intrusive obsessional thoughts and compulsive behaviors driven partly by dysfunction in cortico-striato-thalamo-cortical circuits — neural loops that become hyperactive and self-reinforcing. Current pharmacological first-line treatments work primarily through the serotonin system. Ketamine’s NMDA receptor antagonism offers a different pathway: by modulating glutamate transmission in these corticostriatal circuits, ketamine may interrupt the pathological loop activity that sustains OCD symptomatology. Research from Yale School of Medicine and other institutions has found that ketamine produced significantly faster and more pronounced reductions in OCD symptoms compared to placebo in early trial data, with effects observed within hours to days. To better understand the neurochemical basis of this effect, see our deep dive on the ketamine glutamate system and brain chemistry.
What the Current Evidence Actually Shows
We want to be precise about the evidence level: the published randomized controlled trial data for ketamine in OCD specifically is limited compared to the TRD evidence base. The most prominent study, published in Neuropsychopharmacology, involved a small patient population, and larger replication studies are still underway. We discuss this openly in every OCD consultation. The mechanism is compelling, the early results are encouraging, and the clinical need is real — but patients deserve to know they are entering a space where the evidence is still maturing.
How Edelica Health Evaluates OCD Patients for Ketamine
Our approach to OCD at Edelica Health begins with a careful evaluation of whether your OCD presentation meets criteria for a ketamine trial. We assess the severity and duration of your symptoms, prior treatment attempts, comorbid conditions — depression and anxiety are extremely common in OCD populations — and any contraindications. For OCD specifically, we also explore whether you are engaged in ongoing exposure and response prevention therapy, since the post-ketamine window of neuroplasticity may represent an optimal time for ERP work to be most effective. We encourage every patient considering ketamine for OCD to maintain an active therapeutic relationship with an OCD-specialized therapist.
Addressing Common Concerns About the Ketamine Experience
One barrier we frequently hear from OCD patients is the fear that the ketamine experience itself will trigger or exacerbate obsessional thinking. This is a legitimate clinical consideration. The dissociative state produced by ketamine can activate unusual thoughts or perceptual experiences, and for patients whose OCD involves contamination fears or harm obsessions, this requires careful preparation and the right clinical environment. Our team spends significant time in pre-infusion preparation for OCD patients, addressing the specific character of their obsessions and creating a framework for working with unusual experiences during the infusion rather than against them. If you want to know what to expect before your first session, our guide on first ketamine infusion preparation in Milwaukee walks through the process in detail. The goal is that the ketamine session feels structured and supported rather than destabilizing.
The second barrier is the question of whether any psychiatric treatment can realistically make a dent in OCD when years of prior treatment have not. We hear this from patients who have tried multiple SSRIs at high doses, completed courses of ERP, tried augmentation strategies, and still find themselves spending hours a day in compulsive rituals that they know are irrational but cannot stop. Our honest answer is that ketamine is not a cure for OCD, and we do not describe it as one. What the evidence and our clinical experience suggest is that it may reduce the intensity and rigidity of obsessional thinking during the period of its effect, potentially creating a window of greater cognitive flexibility. Results vary by individual, and we discuss realistic expectations openly.
When OCD and Depression Overlap
For patients whose OCD is comorbid with depression — which is more the rule than the exception — ketamine’s dual impact on mood and obsessional thinking may be clinically meaningful. Reducing the depressive element of OCD often makes the ERP work more accessible and sustains motivation for treatment. We consider the full picture of your mental health presentation rather than treating OCD as a single isolated diagnosis. Our article on how ketamine helps depression explores this mechanism further for patients dealing with overlapping mood symptoms.
Frequently Asked Questions
Is ketamine FDA-approved for OCD?
No. Ketamine’s use for OCD is off-label. There is no FDA-approved indication for ketamine in OCD treatment. Its use in this context is based on emerging clinical research and a plausible neurobiological mechanism, but evidence is more preliminary than for treatment-resistant depression. Always discuss your options with a qualified provider.
How quickly might ketamine affect OCD symptoms?
Early research, including a Yale study published in Neuropsychopharmacology, found meaningful reductions in OCD symptom severity within hours to days of a ketamine infusion — faster than any serotonergic medication. However, results vary significantly by individual, and this should not be interpreted as a guarantee of effect.
Should I stop ERP therapy while doing ketamine at Edelica Health?
No — we strongly encourage maintaining your existing OCD therapy. The window of neuroplasticity and reduced rigidity following ketamine infusions may actually enhance the effectiveness of ERP. We work collaboratively with your existing therapist where possible.
Is ketamine safe for patients who have OCD with harm obsessions?
OCD with harm obsessions requires careful clinical evaluation and thorough pre-infusion preparation. Our team specifically addresses the character of your obsessions before your first session to ensure the infusion environment and preparation minimize the risk of distress. This is a patient-by-patient clinical decision made in consultation.
Can SPRAVATO® help OCD?
SPRAVATO® (esketamine) is FDA-approved specifically for treatment-resistant depression and MDD with acute suicidal ideation or behavior — it is not approved for OCD. If your OCD co-occurs with TRD, SPRAVATO® may be relevant to the depressive component. Discuss your complete clinical picture with our team.
Key Takeaways
- Ketamine’s NMDA receptor antagonism may interrupt corticostriatal circuit hyperactivity that drives OCD, offering a mechanistically distinct option from serotonergic medications.
- The published clinical evidence for ketamine in OCD is encouraging but more preliminary than for TRD; honest expectations are essential.
- Edelica Health prepares OCD patients specifically for the dissociative infusion experience, addressing the potential interaction with obsessional thinking styles.
- Maintaining ERP therapy alongside ketamine is strongly encouraged, as the neuroplasticity window may enhance therapeutic outcomes.
- Results vary by individual; a thorough consultation is required to assess candidacy and design an appropriate protocol.
Severe, treatment-resistant OCD can be one of the most isolating conditions in psychiatry. At Edelica Health, we believe that patients who have tried first-line treatments without adequate relief deserve access to every evidence-informed option available. If you or someone you care for is living with OCD in Milwaukee or the surrounding Wisconsin region, we invite you to explore whether ketamine therapy may be a meaningful addition to your treatment plan. Discuss your full history with your provider, and contact us to schedule a consultation with our team for an honest, thorough evaluation.
About Dr. Kevin Kane
Dr. Kevin Kane, MD founded Edelica Health (formerly Ketamine Milwaukee) and Sana Medical in 2017, opening Wisconsin’s first private ketamine clinic. A physician anesthesiologist nationally known in the ketamine space, he serves as medical director of both Edelica Health and Sana Medical and has personally administered or overseen over 10,000 ketamine infusions. Dr. Kane was born and raised in Wisconsin, a graduate of UW-Milwaukee (1989), and completed both his MD (1993) and residency (1997) at the Medical College of Wisconsin. He is board-certified by the American Board of Anesthesiology and has been a member of ASKP3 since its inception. Edelica Health has been featured on CNN as the preeminent ketamine infusion provider in the Milwaukee area. His clinical team includes psychiatric mental health nurse practitioner Megan Sloan.
References
Neuropsychopharmacology — Ketamine and OCD (Yale Study): https://www.nature.com/npp
International OCD Foundation — Treatment Overview and Statistics: https://iocdf.org/about-ocd/
National Institute of Mental Health — OCD Information: https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd
American Psychiatric Association — OCD Treatment Guidelines: https://www.psychiatry.org/patients-families/ocd
American Society of Ketamine Physicians, Psychotherapists & Practitioners (ASKP3): https://www.askp3.org/
Medical Disclaimer
The content on this page is provided by Edelica Health for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Ketamine’s use for OCD is off-label and the evidence base is still emerging. Individual results vary. This content does not replace evaluation and guidance from a qualified psychiatric provider specializing in OCD. Always discuss your full mental health history, current treatments, and options with a licensed healthcare provider before making any changes to your care. If you are experiencing a mental health crisis, please call or text 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room.